https://www.selleckchem.com/products/pomhex.html
31 (1.14-4.68, 0.02), and age at transplantation, with a RR of 1.03 (1-1.06, 0.034), as significant for survival. Patients resuming smoking after transplantation had a significantly higher risk of dying from solid organ cancer, with a RR of 2.54 (1.03, 6.28; 0.04) with a short median survival time (25th-75th percentile) of (1 (0-5) months, 0.007). Patients who resume smoking after heart transplantation have worse survival and are at higher risk of dying from solid organ cancer. Implementing a smoking cessation plan throughout the post-tr